Contribution of 11C-Choline Positron Emission Tomography/Computerized Tomography to Preoperative Staging of Advanced Transitional Cell Carcinoma

Journal of Urology

Volumn 176, Issue 3, 2006, Pages 940-944

  Gofrit, Ofer N ^a   Mishani, Eyal ^a   Orevi, Marina ^a   Klein, Martine ^a   Freedman, Nanette ^a   Pode, Dov ^a   Shapiro, Amos ^a   Katz, Ran ^a   Libson, Eugene ^a   Chisin, Roland ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

carcinoma; methyl carbon 11 choline; positron emission tomography; tomography; transitional cell; x ray computed

Indexed keywords

CARBON 11; CHOLINE; CARBON; DIAGNOSTIC AGENT;

ABDOMEN; AGED; ARTICLE; BLADDER CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STANDARDIZATION; THORAX; TRANSITIONAL CELL CARCINOMA; BLADDER TUMOR; CASE REPORT; DISEASE COURSE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOGRAPHY; SCINTISCANNING;

AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CARCINOMA, TRANSITIONAL CELL; CHOLINE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER NEOPLASMS;

EID: 33746542141     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.04.018     Document Type: Article

References (19)

1. Paik M.L., Scolieri M.J., Brown S.L., Spirnak J.P., and Resnick M.I. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163 (2000) 1693
2. Jakse, G., Algaba, F., Fossa, S., Stenzl, A. and Sternberg, C.: Muscle invasive bladder cancer. In: Urological Guidelines. European Association of Urology, Board EAU Guidelines Office, August 2004
3. Herr H.W. Routine CT scan in cystectomy patients. does it change management?. Urology 47 (1996) 324
4. Kim B., Semelka R.C., Ascher S.M., Chalpin D.B., Carroll P.R., and Hricak H. Bladder tumor staging. comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 193 (1994) 239
5. Narumi Y., Kadota T., Inoue E., Kuriyama K., Horinouchi T., Kasai K., et al. Bladder tumors. staging with gadolinium-enhanced oblique MR imaging. Radiology 87 (1993) 145
6. Jager G.J., Barentsz J.O., Oosterhof G.O., Witjes J.A., and Ruijs S.J. Pelvic adenopathy in prostatic and urinary bladder carcinoma. MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol 167 (1996) 1503
7. Deserno W.M., Harisinghani M.G., Taupitz M., Jager G.J., Witjes J.A., Mulders P.F., et al. Urinary bladder cancer. preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233 (2004) 449
8. Scolieri M.J., Paik M.L., Brown S.L., and Resnick M.I. Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 56 (2000) 930
9. Thie J.A. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med 45 (2004) 1431
10. Heicappell R., Muller-Mattheis V., Reinhardt M., Vosberg H., Gerharz C.D., Muller-Gartner H., et al. Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol 36 (1999) 582
11. Bachor R., Kotzerke J., Reske S.N., and Hautmann R. Lymph node staging of bladder neck carcinoma with positron emission tomography. Urologe A 38 (1999) 46
12. Roivainen A., Forsback S., Gronroos T., Lehikoinen P., Kahkonen M., Sutinen E., et al. Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography. Eur J Nucl Med 27 (2000) 25
13. Hara T., Kosaka N., and Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 39 (1998) 990
14. de Jong I.J., Pruim J., Elsinga P.H., Jongen M.M., Mensink H.J., and Vaalburg W. Visualisation of bladder cancer using (11)C-choline PET. first clinical experience. Eur J Nucl Med Mol Imaging 29: (2002) 1283
15. Antoch G., Saoudi N., Kuehl H., Dahmen G., Muller S.P., Beyer T., et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors. comparison with CT and PET. J Clin Oncol 22 (2004) 4357
16. Antoch G., Vogt F.M., Freudenberg L.S., Nazadeh F., Goehde S.C., Barkhausen J., et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290 (2003) 3199
17. Mishani E., Ben-David I., Rozen Y., Laki D., Bocher M., and Chisin R. [C-11]choline-Automated preparation and clinical utilization. J Labelled Comp Radiopharm 44 (2001) 379
18. Mishani E., Ben-David I., and Rozen Y. Improved method for the quality assurance of [C-11]choline. Nucl Med Biol 29 (2002) 359
19. Nakamoto Y., Osman M., Cohade C., Marshall L.T., Links J.M., Kohlmyer S., et al. PET/CT. comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med 43 (2002) 1137